RAYMOND NG
No ORCID on file
· 17 papers in corpus
· active 2009
Frequent coauthors
- JIAYI XU 17
- ZHIHUA SUI 17
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…
2009
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceuticalcompositions contianing them, their use in the treatment and/or prevention of disorders mediated by oneor more estrogen receptors and pr…